hyungji Elite Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

hyungji Elite şirketinin toplam hissedar öz sermayesi ₩80.4B ve toplam borcu ₩28.2B olup, bu da borç-öz sermaye oranını 35.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₩142.9B ve ₩62.5B dir. hyungji Elite 'in FAVÖK'ü ₩7.7B faiz karşılama oranı -67.2 dur. Şirketin ₩8.7B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

35.1%

Borç/özkaynak oranı

₩28.24b

Borç

Faiz karşılama oranı	-67.2x
Nakit	₩8.69b
Eşitlik	₩80.36b
Toplam yükümlülükler	₩62.49b
Toplam varlıklar	₩142.85b

Son finansal sağlık güncellemeleri

Recent updates

Impressive Earnings May Not Tell The Whole Story For hyungji Elite (KRX:093240)

Nov 21

hyungji Elite (KRX:093240) Has A Pretty Healthy Balance Sheet

Nov 15

hyungji Elite Co., Ltd. (KRX:093240) Surges 45% Yet Its Low P/E Is No Reason For Excitement

Sep 24

hyungji Elite Co., Ltd.'s (KRX:093240) Share Price Could Signal Some Risk

Aug 05

We Think hyungji Elite (KRX:093240) Can Stay On Top Of Its Debt

Mar 28

Is hyungji Elite's (KRX:093240) Share Price Gain Of 220% Well Earned?

Feb 01

Is hyungji Elite (KRX:093240) A Risky Investment?

Dec 28

hyungji Elite Co., Ltd.'s (KRX:093240) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Nov 23

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A093240 'nin kısa vadeli varlıkları ( ₩92.8B ) kısa vadeli yükümlülüklerini ( ₩46.3B ) aşıyor.

Uzun Vadeli Yükümlülükler: A093240 şirketinin kısa vadeli varlıkları ( ₩92.8B ) uzun vadeli yükümlülüklerini ( ₩16.2B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A093240 'nin net borç/öz sermaye oranı ( 24.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: A093240 'nin borç/öz sermaye oranı son 5 yılda 41.9% seviyesinden 35.1% seviyesine düştü.

Borç Kapsamı: A093240 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: A093240 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

hyungji Elite Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

hyungji Elite (KRX:093240) Has A Pretty Healthy Balance Sheet

We Think hyungji Elite (KRX:093240) Can Stay On Top Of Its Debt

Is hyungji Elite (KRX:093240) A Risky Investment?

Recent updates

Impressive Earnings May Not Tell The Whole Story For hyungji Elite (KRX:093240)

First quarter 2025 earnings released: EPS: ₩34.00 (vs ₩36.00 in 1Q 2024)

Investor sentiment deteriorates as stock falls 15%

hyungji Elite (KRX:093240) Has A Pretty Healthy Balance Sheet

Investor sentiment deteriorates as stock falls 20%

New minor risk - Shareholder dilution

Investor sentiment improves as stock rises 17%

hyungji Elite Co., Ltd. (KRX:093240) Surges 45% Yet Its Low P/E Is No Reason For Excitement

New minor risk - Share price stability

Full year 2024 earnings released: EPS: ₩207 (vs ₩65.00 in FY 2023)

hyungji Elite Co., Ltd., Annual General Meeting, Sep 30, 2024

Now 20% overvalued

hyungji Elite Co., Ltd.'s (KRX:093240) Share Price Could Signal Some Risk

Second quarter 2024 earnings released: ₩2.00 loss per share (vs ₩5.00 profit in 2Q 2023)

hyungji Elite Co., Ltd. announced that it has received KRW 3.5 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm

hyungji Elite Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm

First quarter 2024 earnings released: EPS: ₩36.00 (vs ₩4.00 loss in 1Q 2023)

Full year 2023 earnings released: EPS: ₩65.00 (vs ₩262 in FY 2022)

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩35.00 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₩5.00 (vs ₩61.00 in 2Q 2022)

First quarter 2023 earnings released: ₩4.00 loss per share (vs ₩17.00 loss in 1Q 2022)

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: ₩262 (vs ₩24.00 loss in FY 2021)

Less than half of directors are independent

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

First quarter 2022 earnings released: ₩17.00 loss per share (vs ₩35.00 loss in 1Q 2021)

Full year 2021 earnings released: ₩24.00 loss per share (vs ₩36.00 loss in FY 2020)

Investor sentiment deteriorated over the past week

hyungji Elite Co., Ltd. announced that it has received KRW 10 billion in funding

hyungji Elite Co., Ltd. announced that it expects to receive KRW 10 billion in funding

Third quarter 2021 earnings released: EPS ₩46.00 (vs ₩48.00 loss in 3Q 2020)

We Think hyungji Elite (KRX:093240) Can Stay On Top Of Its Debt

Second quarter 2021 earnings released: EPS ₩39.00 (vs ₩57.00 in 2Q 2020)

Is hyungji Elite's (KRX:093240) Share Price Gain Of 220% Well Earned?

New 90-day high: ₩4,105

Is hyungji Elite (KRX:093240) A Risky Investment?

New 90-day high: ₩3,275

hyungji Elite Co., Ltd.'s (KRX:093240) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

First quarter 2021 earnings released: ₩35.00 loss per share

New 90-day high: ₩2,335

Full year earnings released - ₩41.16 loss per share

New 90-day high - ₩2,295

New 90-day high - ₩2,185

New 90-day high - ₩1,565

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin